Photo of Megan Murray

Megan Murray, M.D., Sc.D.

Ronda Stryker and William Johnston Professor of Global Health, Harvard Medical School
Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health
Associate Professor of Medicine, Brigham and Women's Hospital
Director of Research, Global Health & Social Medicine, Harvard Medical School

Megan Murray, MD, MPH, ScD is an epidemiologist and an infectious disease physician with over 25 years of experience in the management of TB programs and TB epidemiology, as well as the transmission dynamics of emerging infectious diseases. She is a Professor of Global Health and Social Medicine and an Associate Professor of Medicine at Harvard Medical School, where she leads the Global Health Research Core, a multidisciplinary group of researchers who work with the Global Health Delivery Partnership faculty and staff to develop its mission to link research to the teaching and service activities of the Partnership. She is also a Professor of Epidemiology at Harvard School of Public Health and the Director of Research at the Brigham and Women’s Hospital Division of Global Health Equity and its sister organization, Partners In Health.  Dr. Murray has conducted field studies in Peru, Rwanda, South Africa, Ukraine, Russia and the US, and has previously worked in Kenya, Niger and Pakistan. Her current interests include identifying ways to reduce the suffering caused by the health impacts of climate change, especially in low and middle income countries.

Address: 
Department of Global Health and Social Medicine
641 Huntington Avenue
Boston, MA 02115

Alternative email address: mmurray@hsph.harvard.edu

Dr. Murray’s research focuses on host and pathogen specific determinants of TB infection, disease and treatment outcomes. Much of her research is done in collaboration with the non-governmental organization Partners in Health and its Peru-based sister organization Socios en Salud. The joint team uses bacterial and human genetic and genomic tools to identify variants of interest and to understand the mechanisms of their interactions.

In addition to her work in Peru, Dr. Murray has conducted field studies in South Africa, Russia, the US, India, Indonesia, Sierra Leone, Pakistan, Niger and Rwanda. She serves as an editor for PLoS Medicine and for the European Journal of Epidemiology. She is currently a member of the Mass Consortium for Pathogen Readiness leadership team as well as Harvard University’s Covid Monitoring Committee. She has also served on numerous other committees, including the WHO’s TB-STAG, the Stop TB MDR Working Group, Harvard University Human Subjects Committee, the University’s Pandemic Flu Advisory Committee, the Institute of Medicine committee on Gulf War and Infectious Diseases, and multiple NIH study sections.

Clustering of Mycobacterium tuberculosis strains from foreign-born patients in Korea.
Authors: Authors: Jeon CY, Kang H, Kim M, Murray MB, Kim H, Cho EH, Park YK.
J Med Microbiol
View full abstract on Pubmed
The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis.
Authors: Authors: Harries AD, Lin Y, Satyanarayana S, Lönnroth K, Li L, Wilson N, Chauhan LS, Zachariah R, Baker MA, Jeon CY, Murray MB, Maher D, Bygbjerg IC, Enarson DA, Billo NE, Kapur A.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Food insufficiency is a risk factor for suboptimal antiretroviral therapy adherence among HIV-infected adults in urban Peru.
Authors: Authors: Franke MF, Murray MB, Muñoz M, Hernández-Díaz S, Sebastián JL, Atwood S, Caldas A, Bayona J, Shin SS.
AIDS Behav
View full abstract on Pubmed
Bayesian methods for fitting mixture models that characterize branching tree processes: An application to development of resistant TB strains.
Authors: Authors: Izu A, Cohen T, Mitnick C, Murray M, De Gruttola V.
Stat Med
View full abstract on Pubmed
Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa.
Authors: Authors: Jacobson KR, Theron D, Victor TC, Streicher EM, Warren RM, Murray MB.
Clin Infect Dis
View full abstract on Pubmed
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.
Authors: Authors: Louw GE, Warren RM, Gey van Pittius NC, Leon R, Jimenez A, Hernandez-Pando R, McEvoy CR, Grobbelaar M, Murray M, van Helden PD, Victor TC.
Am J Respir Crit Care Med
View full abstract on Pubmed
The impact of diabetes on tuberculosis treatment outcomes: a systematic review.
Authors: Authors: Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, Ottmani SE, Goonesekera SD, Murray MB.
BMC Med
View full abstract on Pubmed
Modeling social, environmental and biological determinants of tuberculosis.
Authors: Authors: Murray M, Oxlade O, Lin HH.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Epidemiologic inference from the distribution of tuberculosis cases in households in Lima, Peru.
Authors: Authors: Brooks-Pollock E, Becerra MC, Goldstein E, Cohen T, Murray MB.
J Infect Dis
View full abstract on Pubmed
Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru.
Authors: Authors: Cohen T, Murray M, Abubakar I, Zhang Z, Sloutsky A, Arteaga F, Chalco K, Franke MF, Becerra MC.
Emerg Infect Dis
View full abstract on Pubmed